Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Cholesterol Medicines:Side Effects May Outweigh Benefits

MEDIA RELEASE                                                                         

3 JUNE 2013

Cholesterol-lowering Medicines In Elderly People: Side Effects May Outweigh Benefits

At least four in every ten Australians over the age of 65 are taking a cholesterol-lowering medicine, with statins such as atorvastatin, simvastatin and rosuvastatin the most commonly prescribed. However, according to an article in the June edition of Australian Prescriber, the risk of side effects in frail elderly people may outweigh the benefits of continuing on a statin.

Associate Professor Sarah Hilmer and Dr Danijela Gnjidic of the University of Sydney say that statins lower the chance of a heart attack or death in older people who have already had a heart attack. However, the benefit of statins in older people who do not already have heart disease is less clear.

“Statins can cause side effects, and these are more likely in people aged over 70, especially those taking several other medicines,” write the authors.

“Muscle pain or muscle damage are the most common side effects that cause people to stop treatment. Statins can also cause liver problems,” said the authors.

“Statins have also been found to contribute to memory loss or confusion in some people. This side effect may be reversed when statins are stopped.”

NPS MedicineWise clinical adviser Dr Philippa Binns says that it is important that people who have questions or concerns about their medicines talk to their doctor to get personalised advice.

“The benefits of a medicine must always be balanced against the harms,” says Dr Binns.

“It’s also natural that your priorities and your ability to tolerate a medicine may change over time. What’s important is that you don’t stop taking your medicine without consulting your doctor.”

To read the full article and others visit www.australianprescriber.com

People with questions about their medicine can call the NPS Medicines Line (1300 MEDICINE or 1300 633 424), Monday to Friday 9am to 5pm AEST.

ENDS.

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Final Frontier: Rocket Lab And NASA Sign Commercial Space Launch Agreement

Rocket Lab has signed a Commercial Space Launch Act Agreement with the National Aeronautics and Space Administration (NASA). The agreement enables Rocket Lab to use NASA resources - including personnel, facilities and equipment - for launch and reentry efforts. More>>

ALSO:

Scoop Business: Wheeler Downplays Scope For ‘Large’ Rates Fall

Reserve Bank governor Graeme Wheeler says some market commentators are predicting further declines in interest rates that would only make sense for an economy in recession, although some easing is likely to be needed to maintain New Zealand’s economic growth. More>>

ALSO:

Ruataniwha Dam: Consent Conditions Could Mean Reduced Intensity

Legal advice sought by the Hawke’s Bay Regional Council on the Ruataniwha Dam consent conditions has confirmed that farmers who sign up to take water from the dam could be required to reduce the intensity of their farming operation to meet the catchment’s strict nitrogen limit. More>>

Health And Safety: Bill Now Sees Rules Relaxed For Small Businesses

Health and safety law reform sparked by the Pike River coalmine disaster has been reported back from the industrial relations select committee with weakened requirements on small businesses to appoint health and safety representatives and committees. More>>

ALSO:

Bearing Fruit: Annual Fruit Exports Hit $2 Billion For First Time

The value of fruit exported rose 20 percent (up $330 million) for the June 2015 year when compared with the year ended June 2014. Both higher prices and a greater quantity of exports (up 9.0 percent) contributed to the overall rise. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news